4/A//SEC Filing
SUN PHARMA GLOBAL INC 4/A
Accession 0000947871-10-001036
CIK 0000906338other
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 3:41 PM ET
Size
23.4 KB
Accession
0000947871-10-001036
Insider Transaction Report
Form 4/AAmended
Alkaloida Chemical CO Exclusive Group Ltd.
10% OwnerOther
Transactions
- Purchase
Ordinary Shares
2010-11-04$16.00/sh+5,159,765$82,556,240→ 14,497,933 total(indirect: See Footnote)
SUN PHARMA GLOBAL INC
10% OwnerOther
Transactions
- Purchase
Ordinary Shares
2010-11-04$16.00/sh+5,159,765$82,556,240→ 14,497,933 total(indirect: See Footnote)
SUN PHARMACEUTICAL INDUSTRIES LTD
10% OwnerOther
Transactions
- Purchase
Ordinary Shares
2010-11-04$16.00/sh+5,159,765$82,556,240→ 14,497,933 total(indirect: See Footnote)
Footnotes (4)
- [F1]Equivalent to Common Stock. All Ordinary Shares of Taro Pharmaceutical Industries Ltd. (the "Issuer") control in the aggregate two-thirds of the voting power of the Issuer.
- [F2]This amount represents 58,000 Ordinary Shares acquired by Sun Pharma Global, Inc. ("Sun Pharma"), a direct wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd. ("Sun"), on July 7, 2007 and 500 Ordinary Shares acquired by Sun Pharma on July 23, 2007, in each case in open market transactions; 3,712,557 Ordinary Shares acquired by Alkaloida Chemical Company Exclusive Group Ltd. ("Alkaloida"), an indirect subsidiary of Sun, on February 19, 2008 and 797,870 Ordinary Shares acquired by Alkaloida on June 23, 2008, in each case in a private transaction; 29,382 Ordinary Shares acquired by Alkaloida on September 14, 2010 upon the expiration of its tender offer to acquire all of Issuer's outstanding Ordinary Shares; and 2,405,937 Ordinary Shares acquired by Alkaloida pursuant to a letter agreement dated September 20, 2010.
- [F3]This amount also includes 2,333,922 Ordinary Shares indirectly acquired by Sun Pharmaceutical Industries Inc. ("Sun Michigan"), a Michigan corporation and a direct subsidiary of Sun, through a merger of a subsidiary of Sun Michigan with and into The Taro Development Corporation on October 1, 2010; and 5,159,765 Ordinary Shares acquired by Alkaloida on November 4, 2010 from Templeton Asset Management Ltd in a private transaction.
- [F4]In addition, Sun indirectly owns 13,575,000 Ordinary Shares which are restricted stock consisting of: (i) 3,770,833 Ordinary Shares acquired by Alkaloida on May 21, 2007 and 3,016,667 Ordinary Shares acquired by Alkaloida on May 30, 2007, in each case pursuant to the share purchase agreement dated May 18, 2007, between Alkaloida and the Issuer; (ii) 3,000,000 Ordinary Shares acquired by Alkaloida on August 2, 2007, pursuant to Sun's rights under the warrant, dated May 18, 2007, issued by the Issuer to Sun, and (iii) 3,712,500 Ordinary Shares acquired by Alkaloida on September 24, 2010 and 75,000 Ordinary Shares acquired by Alkaloida on September 27, 2010, in each case pursuant to a warrant dated August 2, 2007, between Sun and the Issuer.
Issuer
TARO PHARMACEUTICAL INDUSTRIES LTD
CIK 0000906338
Entity typeother
Related Parties
1- filerCIK 0001197088
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 3, 8:00 PM ET
- Accepted
- Nov 4, 3:41 PM ET
- Size
- 23.4 KB